Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Gautam R Ashra has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201101-08-2015
01-08-2015
Shareholding Pattern For June 30, 2015
Bliss GVS Pharma Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.16-07-2015
Revised Book Closure for Final Dividend & AGM
Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 10, 2015 to September 16, 2015 (both days inclusive) (Revised) for the purpose of Payment of Final Dividend & Annual General Meeting (AGM) of the Company to be held on September 16, 2015.07-07-2015
Bliss GVS Healthcare wins USD 35 Million contract for Medical Healthcare Services in Kenya
Bliss GVS Pharma Ltd has informed BSE regarding "Bliss GVS Healthcare wins USD 35 Million contract for Medical Healthcare Services in Kenya".02-07-2015
Bliss GVS Pharma entry into Managed Healthcare Services in Africa
Bliss GVS Pharma Ltd has informed BSE regarding "Bliss GVS Pharma entry into Managed Healthcare Services in Africa".02-07-2015
Fixes Book Closure for Final Dividend & AGM
Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 07, 2015 to September 11, 2015 (both days inclusive) for the purpose of Payment of Final Dividend & 30th Annual General Meeting (AGM) of the Company to be held on September 16, 2015.01-06-2015
Board recommends Final Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has considered and approved the followings:1. Declared Final Dividend at the rate of 50% i.e. Re. 0.50 per share.2. Sale of Step Down subsidiary Surgimed Pharma Limited located at Kenya;3. Due to ill health Mr. G.G Desai resigned from the Board;...30-05-2015
Code of Conduct of Fair Disclosure
Bliss GVS Pharma Ltd has informed BSE about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015.29-05-2015
Financial Results for March 31, 2015 (Audited)
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2015.29-05-2015